Free Trial

Heartland Bank & Trust Co Invests $516,000 in MetLife, Inc. (NYSE:MET)

MetLife logo with Finance background

Heartland Bank & Trust Co bought a new position in shares of MetLife, Inc. (NYSE:MET - Free Report) during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 6,426 shares of the financial services provider's stock, valued at approximately $516,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in MET. Norges Bank bought a new stake in MetLife during the fourth quarter worth $730,716,000. Price T Rowe Associates Inc. MD raised its position in MetLife by 33.7% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 24,663,239 shares of the financial services provider's stock worth $2,019,427,000 after acquiring an additional 6,213,923 shares in the last quarter. Bank of New York Mellon Corp raised its position in MetLife by 109.2% during the fourth quarter. Bank of New York Mellon Corp now owns 8,826,658 shares of the financial services provider's stock worth $722,727,000 after acquiring an additional 4,606,748 shares in the last quarter. Clearbridge Investments LLC raised its position in MetLife by 43.7% during the fourth quarter. Clearbridge Investments LLC now owns 5,663,177 shares of the financial services provider's stock worth $463,701,000 after acquiring an additional 1,723,461 shares in the last quarter. Finally, Northern Trust Corp raised its position in MetLife by 15.7% during the fourth quarter. Northern Trust Corp now owns 7,052,202 shares of the financial services provider's stock worth $577,434,000 after acquiring an additional 958,458 shares in the last quarter. 94.99% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on MET. JPMorgan Chase & Co. dropped their price objective on shares of MetLife from $88.00 to $86.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 2nd. Keefe, Bruyette & Woods lowered their price target on shares of MetLife from $98.00 to $95.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 9th. UBS Group raised their price target on shares of MetLife from $94.00 to $98.00 and gave the stock a "buy" rating in a research report on Wednesday, April 2nd. Morgan Stanley increased their price objective on shares of MetLife from $94.00 to $99.00 and gave the stock an "overweight" rating in a research note on Monday, May 19th. Finally, Piper Sandler increased their price objective on shares of MetLife from $92.00 to $94.00 and gave the stock an "overweight" rating in a research note on Wednesday, April 2nd. Two investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $94.17.

View Our Latest Stock Analysis on MetLife

MetLife Trading Up 0.6%

NYSE:MET traded up $0.48 during mid-day trading on Monday, hitting $79.69. 2,383,659 shares of the company's stock were exchanged, compared to its average volume of 3,377,119. The company has a 50 day simple moving average of $77.37 and a 200-day simple moving average of $80.24. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.55. MetLife, Inc. has a fifty-two week low of $65.21 and a fifty-two week high of $89.05. The firm has a market capitalization of $53.50 billion, a P/E ratio of 12.96, a PEG ratio of 0.63 and a beta of 0.86.

MetLife (NYSE:MET - Get Free Report) last posted its earnings results on Wednesday, April 30th. The financial services provider reported $1.96 EPS for the quarter, missing the consensus estimate of $2.00 by ($0.04). MetLife had a return on equity of 20.89% and a net margin of 6.08%. The business had revenue of $18.57 billion for the quarter, compared to analyst estimates of $18.06 billion. During the same quarter in the prior year, the business earned $1.83 earnings per share. The firm's quarterly revenue was up 15.6% on a year-over-year basis. As a group, research analysts expect that MetLife, Inc. will post 9.65 earnings per share for the current year.

MetLife Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 10th. Investors of record on Tuesday, May 6th were given a dividend of $0.5675 per share. The ex-dividend date was Tuesday, May 6th. This is an increase from MetLife's previous quarterly dividend of $0.55. This represents a $2.27 annualized dividend and a yield of 2.85%. MetLife's dividend payout ratio (DPR) is currently 36.91%.

MetLife declared that its Board of Directors has initiated a share buyback program on Wednesday, April 30th that permits the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization permits the financial services provider to reacquire up to 5.9% of its stock through open market purchases. Stock repurchase programs are often a sign that the company's board believes its shares are undervalued.

MetLife Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

See Also

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Should You Invest $1,000 in MetLife Right Now?

Before you consider MetLife, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.

While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

2 Chip Stocks Are Soaring—But One Could Break Out This Summer
Congress Bought This Stock at the Bottom—Will You Miss It?
These 3 Penny Stocks Could Surprise Everyone This Summer!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines